Your browser doesn't support javascript.
loading
The real-world effectiveness of fluvoxamine therapy in mild to moderate COVID-19 patients; A historical cohort study (Fluvoxa Trial).
Siripongboonsitti, Taweegrit; Tawinprai, Kriangkrai; Payoong, Paruspak; Mahanonda, Nithi.
Affiliation
  • Siripongboonsitti T; Division of Infectious Diseases, Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand; Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand. Electronic address: Taweegrit.sir@cra.ac.th.
  • Tawinprai K; Division of Infectious Diseases, Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand; Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
  • Payoong P; Division of Infectious Diseases, Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Bangkok, Thailand.
  • Mahanonda N; Chulabhorn Royal Academy, Bangkok, Thailand.
J Infect Public Health ; 16(12): 2010-2016, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37890224

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Deterioration / COVID-19 Limits: Humans Language: En Journal: J Infect Public Health Journal subject: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Year: 2023 Document type: Article Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Deterioration / COVID-19 Limits: Humans Language: En Journal: J Infect Public Health Journal subject: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Year: 2023 Document type: Article Country of publication: Reino Unido